valerates - CISMeF

Preferred Label : valerates;

MeSH definition : Derivatives of valeric acid, including its salts and esters.;

MeSH synonym : pentanoates; Valerate; Pentanoate;

MeSH annotation : 2-propylvalerate, 2-propylvaleric acid VALPROATE;

Wikipedia link : https://en.wikipedia.org/wiki/Valerates;

Is substance : O;

Détails

Origin ID

D014631;

UMLS CUI

C0042280;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Indexing information
- 2-ketopentanoic acid [MeSH Supplementary Concept]
- alpha-keto-beta-methylvaleric acid [MeSH Supplementary Concept]
- alpha-ketoisovalerate [MeSH Supplementary Concept]
Record concept(s)
- valerates [MeSH concept]
Related MeSH Supplementary Concept(s)
- ((2-pivaloyloxy-3-isopropylamine)propoxy)phenycarbamic acid, butyl ester [MeSH Supplementary Concept]
- (1-(hydroxymethyl)-4-(4-methyl-3-(methylethyl)pentylidene)-3-oxo-2-oxolanyl)methyl 4-methyl-3-(methylethyl)pentanoate [MeSH Supplementary Concept]
- 2,2-dimethylpropionic acid 3-(2-chloro-6-methylaminopurin-9-yl)-2-(2,2-dimethylpropionyloxymethyl)propyl ester [MeSH Supplementary Concept]
- 2,6-di-O-benzyl-3-O-valeryl-beta-cyclodextrin [MeSH Supplementary Concept]
- 2-bromo-n-valeramide [MeSH Supplementary Concept]
- 2-ethylhydracrylic acid [MeSH Supplementary Concept]
- 2-hydroxyisovaleric acid [MeSH Supplementary Concept]
- 2-hydroxytrideca-3,6-dienylpentanoate [MeSH Supplementary Concept]
- 2-methyl-3-oxopentanoate-S-N-acetylcysteamine [MeSH Supplementary Concept]
- 2-methyl-5-(2',2',3'-trimethylcyclopentyl)-pentane-1- carboxylic acid [MeSH Supplementary Concept]
- 2-methylbutyl 3-methylbutanoate [MeSH Supplementary Concept]
- 2-methylvaleramide [MeSH Supplementary Concept]
- 2beta-(3,4-dimethyl-2,5-dihydro-1H-pyrrol-2-yl)-1'-methylethyl pentanoate [MeSH Supplementary Concept]
- 3-O-benzyl-xylopyranose-1,2,4-orthopivalate [MeSH Supplementary Concept]
- 4,4'-azobis(4-cyanovaleric acid) [MeSH Supplementary Concept]
- 4,5-dioxovaleric acid [MeSH Supplementary Concept]
- 4-(decahydromethyl-3-oxo-1H-cyclopentaquinolinyl)valeric acid [MeSH Supplementary Concept]
- 4-hydroxy-2-oxovalerate [MeSH Supplementary Concept]
- 4-hydroxyisovaleric acid [MeSH Supplementary Concept]
- 4-hydroxyvaleric acid [MeSH Supplementary Concept]
- 4-nitrophenyl trimethylacetate [MeSH Supplementary Concept]
- 4-nitrophenyl valerate [MeSH Supplementary Concept]
- 5-(2-(9-fluorenylmethyloxycarbonyl)aminomethyl-3,5-dimethoxyphenoxy)valeric acid [MeSH Supplementary Concept]
- 5-(4-(9-fluorenylmethyloxycarbonyl)aminomethyl-3,5-dimethoxyphenoxy)valeric acid [MeSH Supplementary Concept]
- 5-(4-formyl-3,5-dimethoxyphenoxy)valeric acid [MeSH Supplementary Concept]
- 5-(4-formyl-3-methoxyphenoxy)valeric acid [MeSH Supplementary Concept]
- 5-chlorovaleryl chloride [MeSH Supplementary Concept]
- 5-hydroxyvaleric acid [MeSH Supplementary Concept]
- 6-isovaleryl-4-methoxy-pyran-2-one [MeSH Supplementary Concept]
- 7,7'-dihydroxy-8,8'- biquinolyl dipentanoate [MeSH Supplementary Concept]
- FR 169824 [MeSH Supplementary Concept]
- FR 184764 [MeSH Supplementary Concept]
- MRJF22 [MeSH Supplementary Concept]
- N,N,N-trimethyl-5-aminovaleric acid [MeSH Supplementary Concept]
- SF 6,5 [MeSH Supplementary Concept]
- Validol [MeSH Supplementary Concept]
- allyl isovalerate [MeSH Supplementary Concept]
- alpha,beta-dihydroxyisovaleric acid [MeSH Supplementary Concept]
- aminoethyl diphenylpropylacetate [MeSH Supplementary Concept]
- asarumin B [MeSH Supplementary Concept]
- asarumin C [MeSH Supplementary Concept]
- benzyl valerate [MeSH Supplementary Concept]
- benzyl-2,2,4,4-tetramethylpentanoate [MeSH Supplementary Concept]
- beta-hydroxyisovaleric acid [MeSH Supplementary Concept]
- cinnamyl isovalerate [MeSH Supplementary Concept]
- citronellyl isovalerate [MeSH Supplementary Concept]
- delta-guanidinovaleric acid [MeSH Supplementary Concept]
- diisovaleryl tert-butalone [MeSH Supplementary Concept]
- dimethylguanidino valerate [MeSH Supplementary Concept]
- ethyl 2-hydroxy-4-methylpentanoate [MeSH Supplementary Concept]
- ethyl isovalerate [MeSH Supplementary Concept]
- ethyl pivalate [MeSH Supplementary Concept]
- ethyl valerate [MeSH Supplementary Concept]
- isobornyl isovalerate [MeSH Supplementary Concept]
- isovalerylglucuronide [MeSH Supplementary Concept]
- jodisol [MeSH Supplementary Concept]
- methyl 3-(2-octadecylcyclopropen--1-yl)pentanoate [MeSH Supplementary Concept]
- methyl 3-hydroxypentanoate [MeSH Supplementary Concept]
- methyl 5-(1'R,2'S)-(2-octadecylcycloprop-1-yl)pentanoate [MeSH Supplementary Concept]
- methyl 5-(5,6-dichloro-2-indolyl)-2-methoxy-2,4-pentadienoate [MeSH Supplementary Concept]
- methyl pentenoate [MeSH Supplementary Concept]
- naltrexone-3-O-valerate [MeSH Supplementary Concept]
- phenethyl isovalerate [MeSH Supplementary Concept]
- phenyl valerate [MeSH Supplementary Concept]
- poly(3-hydroxyvalerate) [MeSH Supplementary Concept]
- sitophilate [MeSH Supplementary Concept]
- trimethyl-N-aminovalerate [MeSH Supplementary Concept]
- valeramide [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Valerates [LOINC hierarchical part]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients